Hansa Biopharma AB Statistics

Total Valuation

STO:HNSA has a market cap or net worth of SEK 2.76 billion. The enterprise value is 3.22 billion.

Market Cap	2.76B
Enterprise Value	3.22B

Important Dates

The next confirmed earnings date is Thursday, July 16, 2026.

Earnings Date	Jul 16, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:HNSA has 101.76 million shares outstanding. The number of shares has increased by 34.63% in one year.

Current Share Class	101.76M
Shares Outstanding	101.76M
Shares Change (YoY)	+34.63%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.31%
Owned by Institutions (%)	18.76%
Float	62.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.47
PB Ratio	-10.01
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.66
EV / Sales	16.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.63

Current Ratio	3.63
Quick Ratio	3.60
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.55

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-38.17%
Return on Invested Capital (ROIC)	-56.51%
Return on Capital Employed (ROCE)	-60.45%
Weighted Average Cost of Capital (WACC)	13.91%
Revenue Per Employee	1.56M
Profits Per Employee	-5.67M
Employee Count	133
Asset Turnover	0.20
Inventory Turnover	17.20

Taxes

In the past 12 months, STO:HNSA has paid 2.38 million in taxes.

Income Tax	2.38M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.25% in the last 52 weeks. The beta is 1.64, so STO:HNSA's price volatility has been higher than the market average.

Beta (5Y)	1.64
52-Week Price Change	-8.25%
50-Day Moving Average	30.73
200-Day Moving Average	31.90
Relative Strength Index (RSI)	34.89
Average Volume (20 Days)	421,280

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:HNSA had revenue of SEK 190.49 million and -691.58 million in losses. Loss per share was -7.71.

Revenue	190.49M
Gross Profit	113.66M
Operating Income	-570.27M
Pretax Income	-689.20M
Net Income	-691.58M
EBITDA	-567.78M
EBIT	-570.27M
Loss Per Share	-7.71

Full Income Statement

Balance Sheet

The company has 676.46 million in cash and 1.14 billion in debt, giving a net cash position of -465.80 million or -4.58 per share.

Cash & Cash Equivalents	676.46M
Total Debt	1.14B
Net Cash	-465.80M
Net Cash Per Share	-4.58
Equity (Book Value)	-275.27M
Book Value Per Share	-2.70
Working Capital	575.46M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-554.28M
Capital Expenditures	n/a
Depreciation & Amortization	2.49M
Net Borrowing	116.16M
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	59.67%
Operating Margin	-299.37%
Pretax Margin	-361.81%
Profit Margin	n/a
EBITDA Margin	-298.07%
EBIT Margin	-299.37%
FCF Margin	n/a

Dividends & Yields

STO:HNSA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.63%
Shareholder Yield	-34.63%
Earnings Yield	-25.10%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3